Increasing Use of Less-Invasive Hemodynamic Monitoring in 3 Specialty Surgical Intensive Care Units: A 5-Year Experience at a Tertiary Medical Center

Introduction: Less-invasive hemodynamic monitoring (eg, esophageal doppler monitoring [EDM] and arterial pressure contour analysis, FloTrac) is increasingly used as an alternative to pulmonary artery catheters (PACs) in critically ill intensive care unit (ICU). Hypothesis: The decrease in use of PAC...

Full description

Saved in:
Bibliographic Details
Published in:Journal of intensive care medicine 2015-01, Vol.30 (1), p.30-36
Main Authors: Kirton, Orlando C., Calabrese, Rebecca C., Staff, Ilene
Format: Article
Language:English
Subjects:
Adult
Catheterization, Swan-Ganz - mortality
Catheterization, Swan-Ganz - trends
Critical Care - methods
Critical Illness - mortality
Critical Illness - therapy
Female
Hemodynamics
Hospital Mortality - trends
Humans
Intensive Care Units
Length of Stay - statistics & numerical data
Male
Middle Aged
Monitoring, Physiologic - mortality
Monitoring, Physiologic - trends
Quality Improvement
Retrospective Studies
Tertiary Care Centers
Vasodilator Agents - administration & dosage
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction: Less-invasive hemodynamic monitoring (eg, esophageal doppler monitoring [EDM] and arterial pressure contour analysis, FloTrac) is increasingly used as an alternative to pulmonary artery catheters (PACs) in critically ill intensive care unit (ICU). Hypothesis: The decrease in use of PACs is not associated with increased mortality. Methods: Five-year retrospective review of 1894 hemodynamically monitored patients admitted to 3 surgical ICUs in a university-affiliate, tertiary care urban hospital. Data included the number of admissions, diagnosis-related group discharge case mix, length of stay, insertion of monitoring devices (PAC, EDM, and FloTrac probes), administered intravenous vasoactive agents (β-predominant agonists—dobutamine, epinephrine, and dopamine; vasopressors—norepinephrine and phenylephrine), and mortality. Data from hospital administrative databases were compiled to create patient characteristic and monitoring variables across a 5-year time period, 2005 to 2009 inclusive. Chi-square for independent proportions, 1-way analysis of variance, and Kruskal-Wallis tests were used; tests for trend were conducted. An α level of .05 was considered significant. Statistical Package for the Social Sciences v14 was used for all statistical testing. Results: There was a significant change in the type of hemodynamic monitors inserted in 2 of the 3 surgical ICUs (in the general surgery and neurointensive care but not in the cardiac ICU) from PACs to less-invasive devices (FloTrac or EDM) during the 5-year study period (P < .001). There was no change in mortality rate over the time period (P = .492). There was an overall increase in the proportion of monitored patients who received intravenous vasoactive agents (P < .001) with a progressive shift from β-agonists to vasopressors (P < .002). Multivariate analyses indicated that age, case mix, and use of vasoactive agents were all independent predictors of inhospital mortality (P = .001) but that type of monitoring was not (P = .638). Conclusions: In a 5-year period, the decreased insertions of PACs were replaced by increased utilization of less-invasive hemodynamic monitoring devices. This change in practice did not adversely impact mortality.
ISSN:0885-0666
1525-1489
DOI:10.1177/0885066613498055